Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -31.2 % |
3 Month Return | -33.35 % |
1 Year Return | -22.57 % |
Market Stats | |
Previous Close | ₹207.90 |
Open | ₹206.90 |
Volume | 9.83L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,002.30Cr |
P/E Ratio | 18.95 |
PEG Ratio | 4.29 |
Market Cap | ₹1,002.30 Cr |
P/B Ratio | 2.99 |
EPS | 10.57 |
Dividend Yield | 1.16 |
Sector | Pharmaceuticals |
ROE | 8.53 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,002.30 Cr | 103.75% | 0.53 | ₹50 Cr | ₹614 Cr | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Kopran Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Kopran Ltd
Kopran's standalone net sales for September 2024 fell 25.46% year-on-year to Rs 73.53 crore. Net profit decreased by 38.07% to Rs 6.60 crore, with EPS dropping to Rs 1.37. The stock has seen negative returns of -14.74% over six months and -23.89% over twelve months.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 142.06 Cr → 152.56 Cr (in ₹), with an average increase of 6.9% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 0.68% to 1.32% in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.49% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 140.0%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 81.1%
Profit Down
Netprofit is down for the last 3 quarters, 18.62 Cr → 7.38 Cr (in ₹), with an average decrease of 37.0% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 54.70% to 53.97% in Sep 2024 quarter
Price Dip
In the last 7 days, KOPRAN stock has moved down by -7.9%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 44.49% | 0.00 | |
Foreign Institutions | 1.32% | 94.32 | |
Mutual Funds | 0% | 50.00 | |
Retail Investors | 53.97% | ||
Others | 0.22% | 62.79 |
Kopran Ltd in the last 5 years
Lowest (3.00x)
March 24, 2020
Today (18.95x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (53.33x)
September 5, 2023
Kopran Ltd’s net profit fell -46.41% since last year same period to ₹7.38Cr in the Q2 2024-2025. On a quarterly growth basis, Kopran Ltd has generated -33.51% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Kopran Ltd has declared dividend of ₹3 - translating a dividend yield of 3.01%.
Read More about DividendsBearish
Neutral
Bullish
Kopran Ltd is currently in a Bearish trading position according to technical analysis indicators.
Kopran Ltd (KOPRAN) share price today is ₹199.55
Kopran Ltd is listed on NSE
Kopran Ltd is listed on BSE
PE Ratio of Kopran Ltd is 18.95
PE ratio = Kopran Ltd Market price per share / Kopran Ltd Earnings per share
Today’s traded volume of Kopran Ltd(KOPRAN) is 9.83L.
Today’s market capitalisation of Kopran Ltd(KOPRAN) is ₹1002.3Cr.
Kopran Ltd(KOPRAN | Price |
---|---|
52 Week High | ₹369.7 |
52 Week Low | ₹198 |
Kopran Ltd(KOPRAN) share price is ₹199.55. It is down -46.02% from its 52 Week High price of ₹369.7
Kopran Ltd(KOPRAN) share price is ₹199.55. It is up 0.78% from its 52 Week Low price of ₹198
Kopran Ltd(KOPRAN | Returns |
---|---|
1 Day Returns | -8.35% |
1 Month Returns | -31.2% |
3 Month Returns | -33.35% |
1 Year Returns | -22.57% |